DE69225706T2 - Humanes galanin, cdna-klone die für humanes galanin kodieren und eine methode humanes galamin herzustellen - Google Patents

Humanes galanin, cdna-klone die für humanes galanin kodieren und eine methode humanes galamin herzustellen

Info

Publication number
DE69225706T2
DE69225706T2 DE69225706T DE69225706T DE69225706T2 DE 69225706 T2 DE69225706 T2 DE 69225706T2 DE 69225706 T DE69225706 T DE 69225706T DE 69225706 T DE69225706 T DE 69225706T DE 69225706 T2 DE69225706 T2 DE 69225706T2
Authority
DE
Germany
Prior art keywords
galanine
humanes
human
galamine
encode
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69225706T
Other languages
English (en)
Other versions
DE69225706D1 (de
Inventor
Helen Evans
John Shine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Garvan Institute of Medical Research
Original Assignee
Garvan Institute of Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Garvan Institute of Medical Research filed Critical Garvan Institute of Medical Research
Application granted granted Critical
Publication of DE69225706D1 publication Critical patent/DE69225706D1/de
Publication of DE69225706T2 publication Critical patent/DE69225706T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69225706T 1991-03-06 1992-03-06 Humanes galanin, cdna-klone die für humanes galanin kodieren und eine methode humanes galamin herzustellen Expired - Lifetime DE69225706T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPK495391 1991-03-06
PCT/AU1992/000097 WO1992015681A1 (en) 1991-03-06 1992-03-06 HUMAN GALANIN, cDNA CLONES ENCODING HUMAN GALANIN AND A METHOD OF PRODUCING HUMAN GALANIN

Publications (2)

Publication Number Publication Date
DE69225706D1 DE69225706D1 (de) 1998-07-02
DE69225706T2 true DE69225706T2 (de) 1998-11-26

Family

ID=3775264

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69225706T Expired - Lifetime DE69225706T2 (de) 1991-03-06 1992-03-06 Humanes galanin, cdna-klone die für humanes galanin kodieren und eine methode humanes galamin herzustellen

Country Status (6)

Country Link
EP (1) EP0587571B1 (de)
JP (1) JP3135262B2 (de)
AT (1) ATE166656T1 (de)
CA (1) CA2105572A1 (de)
DE (1) DE69225706T2 (de)
WO (1) WO1992015681A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2216227A1 (en) 1996-01-24 1997-07-31 Synaptic Pharmaceutical Corporation Dna encoding galanin galr2 receptors and uses thereof
US5972624A (en) * 1996-01-24 1999-10-26 Synaptic Pharmaceutical Corporation Method of identifying ligands which bind recombinant galanin receptor (GALR2)
DK0918455T3 (da) * 1996-07-24 2003-08-04 Neurotargets Ltd Anvendelse af galanin til reparation af nerveskader
US6329197B2 (en) 1996-10-09 2001-12-11 Synaptic Pharmaceutical Corporation DNA encoding galanin GALR3 receptors and uses thereof
EP1037913A4 (de) 1997-12-17 2002-11-20 Merck & Co Inc Galanin rezeptor galr3 und für diesen kodierende nukleotide
EP1177231B1 (de) 1999-04-09 2009-08-19 Invitrogen Dynal AS Verfahren für die herstellung von monodispergierten polymerteilchen
CA2443123A1 (en) 2001-04-10 2002-10-24 Agensys, Inc. Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
US7927597B2 (en) 2001-04-10 2011-04-19 Agensys, Inc. Methods to inhibit cell growth
AU2005299771A1 (en) 2004-10-21 2006-05-04 High Point Pharmaceuticals, Llc Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use
GB0523550D0 (en) 2005-11-18 2005-12-28 Hunter Fleming Ltd Therapeutic uses of steroidal compounds
WO2009039982A2 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1350792A (en) * 1991-01-16 1992-08-27 General Hospital Corporation, The Human galanin
AU1462692A (en) * 1991-02-25 1992-09-15 Board Of Regents Of The University Of Washington, The Methods for detecting galanin antagonists

Also Published As

Publication number Publication date
JP3135262B2 (ja) 2001-02-13
EP0587571A4 (de) 1995-03-15
ATE166656T1 (de) 1998-06-15
JPH06508984A (ja) 1994-10-13
CA2105572A1 (en) 1992-09-07
DE69225706D1 (de) 1998-07-02
EP0587571A1 (de) 1994-03-23
EP0587571B1 (de) 1998-05-27
WO1992015681A1 (en) 1992-09-17

Similar Documents

Publication Publication Date Title
ATE165980T1 (de) Nukleinsaürefragmente, die mannose bindende fragmente vom menschlichen mannosebindenden protein kodieren
ATE229072T1 (de) Für den vorläufer des für die tumorabstossung verantwortlichen antigens mage-3 kodierendes, isoliertes nukleinsäuremolekül und seine verwendung
DE69225706T2 (de) Humanes galanin, cdna-klone die für humanes galanin kodieren und eine methode humanes galamin herzustellen
ATE182901T1 (de) Für androgen-rezeptor-protein kodierende dna
LU93259I2 (fr) LETIFEND (Protein Q)
DK413488D0 (da) Dna-klon med en basissekvens for human vaevsfaktorinhibitor (tfi) og dna-sekvens, der koder for tfi
UY23561A1 (es) Procedimiento para la preparacion de tnf-muteinas
NZ508505A (en) Treatment of wounds using an Egr-1 transcription factor polypeptide
UA39165C2 (uk) Молекула днк, що кодує ліпазу людини, що стимулюється солями жовчних кислот, клонована молекула кднк
ES2114555T3 (es) Nuevo interferon gamma humano recombinado.
HUP9900789A2 (hu) Lefelé irányuló szabályozásra rezisztens C3 konvertáz
EP1270588A4 (de) NEUESKOLLAGEN-äHNLICHES PROTEIN CLAC, DESSEN VORLäUFER UND DAFüR KODIERENDE GENE
DE69536127D1 (de) Transformierender wachstumsfaktor alpha hii
DK0907737T3 (da) IL-6-mutein
DE3777359D1 (de) Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns.
DE60224002D1 (de) Kathepsin Y Inhibitoren für die Entwicklung von Medikamenten zur Schmerzbehandlung
ATE114719T1 (de) Dna-sequenz, beteiligt an der regulation der expression einer dna-sequenz, die einen polypeptid-precursor kodiert, expressionsvektoren und methode der periplasmatischen herstellung des polypeptides.
WO2001083677A3 (fr) Nouveau polypeptide, proteine humaine fh2-13 de deformation des ailes de coq, et polynucleotide codant pour ce polypeptide
YU51601A (sh) Himerni gen koji kodira antigene determinante četiri proteina l.infantum
ATE480560T1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
DK694287A (da) Overfladeaktivt rekombinant-alveolaerprotein

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee
8370 Indication related to discontinuation of the patent is to be deleted